Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

More articles from PERSPECTIVES IN PHARMACOLOGY

  • You have access
    Exploiting Complexity and the Robustness of Network Architecture for Drug Discovery
    Marc K. Hellerstein
    Journal of Pharmacology and Experimental Therapeutics April 2008, 325 (1) 1-9; DOI: https://doi.org/10.1124/jpet.107.131276
  • You have access
    NAD+ and Vitamin B3: From Metabolism to Therapies
    Anthony A. Sauve
    Journal of Pharmacology and Experimental Therapeutics March 2008, 324 (3) 883-893; DOI: https://doi.org/10.1124/jpet.107.120758
  • You have access
    Painful Purinergic Receptors
    Diana Donnelly-Roberts, Steve McGaraughty, Char-Chang Shieh, Prisca Honore and Michael F. Jarvis
    Journal of Pharmacology and Experimental Therapeutics February 2008, 324 (2) 409-415; DOI: https://doi.org/10.1124/jpet.106.105890
  • You have access
    Altered Uric Acid Levels and Disease States
    Melinda K. Kutzing and Bonnie L. Firestein
    Journal of Pharmacology and Experimental Therapeutics January 2008, 324 (1) 1-7; DOI: https://doi.org/10.1124/jpet.107.129031
  • You have access
    Cellular Protection by Erythropoietin: New Therapeutic Implications?
    M. Joyeux-Faure
    Journal of Pharmacology and Experimental Therapeutics December 2007, 323 (3) 759-762; DOI: https://doi.org/10.1124/jpet.107.127357
  • You have access
    Serotonin (5-HT) in Veins: Not All in Vain
    A. Elizabeth Linder, Wei Ni, Jessica L. Diaz, Theodora Szasz, Robert Burnett and Stephanie W. Watts
    Journal of Pharmacology and Experimental Therapeutics November 2007, 323 (2) 415-421; DOI: https://doi.org/10.1124/jpet.107.122630
  • You have access
    Building Individualized Medicine: Prevention of Adverse Reactions to Warfarin Therapy
    Evgeny Krynetskiy and Patrick McDonnell
    Journal of Pharmacology and Experimental Therapeutics August 2007, 322 (2) 427-434; DOI: https://doi.org/10.1124/jpet.106.117952
  • You have access
    Amyloid-β in Alzheimer Disease: The Null versus the Alternate Hypotheses
    Hyoung-gon Lee, Xiongwei Zhu, Rudy J. Castellani, Akihiko Nunomura, George Perry and Mark A. Smith
    Journal of Pharmacology and Experimental Therapeutics June 2007, 321 (3) 823-829; DOI: https://doi.org/10.1124/jpet.106.114009
  • You have access
    Use of Wavelet and Fast Fourier Transforms in Pharmacodynamics
    Donald E. Mager and Darrell R. Abernethy
    Journal of Pharmacology and Experimental Therapeutics May 2007, 321 (2) 423-430; DOI: https://doi.org/10.1124/jpet.106.113183
  • You have access
    Therapeutic Potential of Phosphatidylinositol 3-Kinase Inhibitors in Inflammatory Respiratory Disease
    Kazuhiro Ito, Gaetano Caramori and Ian M. Adcock
    Journal of Pharmacology and Experimental Therapeutics April 2007, 321 (1) 1-8; DOI: https://doi.org/10.1124/jpet.106.111674

Pages

  • Previous
  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 16
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics